Dallan Murray - May 2, 2024 Form 4 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Role
Chief Customer Officer
Signature
/s/ Ryan Brown as Attorney-in-Fact for Dallan Murray
Stock symbol
SRPT
Transactions as of
May 2, 2024
Transactions value $
-$508,900
Form type
4
Date filed
5/6/2024, 08:09 PM
Previous filing
May 6, 2024
Next filing
Jun 25, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRPT Common Stock Sale -$509K -3.64K -16.7% $140.00 18.1K May 2, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024.